"There are no such things as incurable, there are only things for which man has not found a cure."
Bernard Mannes Baruch
Clinical trials are scientific and medical trials conducted on healthy or ill subjects who have voluntarily given their consent to participate.
The development of a new drug takes 10–15 years, from testing 15,000–20,000 molecules to four phases of clinical trials, at a cost exceeding one billion dollars.
Clinical trials are conducted by experts according to a protocol, with informed consent from participants, to assess safety, effectiveness, and quality of life, ensuring continuous protection and monitoring of participants.
Participation in a clinical trial gives participants access to new therapies, enhanced health monitoring, and the opportunity to contribute to medical research, with clearly explained risks and ensured protection.
Every participant in a clinical trial has inalienable rights to informed participation, withdrawal, privacy protection, and safety, while trials are subject to strict ethical, legal, and regulatory rules.
Key concepts in clinical trials include drugs, participants, informed consent, safety, protocols, randomization, placebos, blinding, and ethical and regulatory requirements.
Before participating in a clinical trial, participants should receive clear answers to all questions regarding the purpose, duration, risks, benefits, procedures, obligations, data protection, and support, enabling them to make an informed decision.
For any questions regarding a clinical trial, first contact the investigator or their team, and additional information is available from the Central Ethics Committee, online resources, and patient and family guides.
The website was sponsored by the Innovative pharmaceutical Initiative (iF!). The project was supported by: Central Ethics Committee within the Agency for Medicinal Products and Medical Devices, Croatian Society for Clinical Pharmacology and Therapy of the Croatian Medical Association and Coalition of Associations in Healthcare.
The website was sponsored by the Innovative pharmaceutical Initiative (iF!). The project was supported by: Central Ethics Committee within the Agency for Medicinal Products and Medical Devices, Croatian Society for Clinical Pharmacology and Therapy of the Croatian Medical Association and Coalition of Associations in Healthcare.
